Pangu Venture

Pangu Venture is a venture capital firm that focuses on early-stage investments, particularly in the biotechnology and healthcare sectors. The firm is based in Beijing, China, and has a global investment approach, with offices in various countries, including the United States, Canada, Japan, Singapore, South Africa, South Korea, Taiwan, Finland, Austria, Germany, France, the United Kingdom, Australia, Brazil, India, Russia, Mexico, Italy, and Spain. This international presence allows Pangu Venture to identify and support promising startups across different regions. The firm's investment strategy encompasses a wide range of stages, from Seed and Early Stage to Series A, Series B, Growth, Late Stage, and Pre-IPO. Pangu Venture's diverse portfolio spans multiple industries, including biotechnology, healthcare, technology, consumer goods, energy, financial services, media, telecommunications, retail, transportation, education, real estate, agriculture, manufacturing, and logistics. This broad sector focus enables the firm to leverage cross-industry insights and foster innovation in various fields. Pangu Venture's approach combines hands-on asset management with data-driven underwriting and conservative leverage. The firm emphasizes operational excellence and risk control, aiming to create long-term value for its portfolio companies. By aligning incentives with partners and operators through transparent governance and reporting, Pangu Venture seeks to drive sustainable growth and success in its investments.

Innovative business models, Scalable operations, Strong management teams, Clear path to profitability, Alignment with Pangu Venture's strategic focus areas